fbpx

Jazz Pharmaceuticals Anticompetitive Agreements on Xyrem Complaint

August 14, 2020

In recent years, we’ve seen a number of antitrust cases where a pharmaceutical company with a lucrative drug is accused of conspiring with generics companies to keep generic versions of that drug off the market. This class action alleges that Jazz Pharmaceuticals, related Jazz companies, and a long list of other drug companies conspired to delay the introduction to the market of a generic version of the Jazz narcolepsy drug Xyrem.

Case Event File: Jazz Pharmaceuticals Anticompetitive Agreements on Xyrem Complaint

Related to: Jazz Pharmaceuticals Anticompetitive Agreements on Xyrem Class Action